story of the week
Real-World Evidence of Cabozantinib in Patients With Metastatic Renal Cell Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Real-World Evidence of Cabozantinib in Patients With Metastatic Renal Cell Carcinoma: Results From the CABOREAL Early Access Program
Eur. J. Cancer 2021 Jan 01;142(xx)102-111, L Albiges, A Fléchon, C Chevreau, D Topart, G Gravis, S Oudard, JM Tourani, L Geoffrois, E Meriaux, A Thiery-Vuillemin, P Barthélémy, S Ladoire, B Laguerre, V Perrot, A Billard, B Escudier, M Gross-GoupilFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.